Association Between Serum Bilirubin Levels and Progression of Albuminuria in Taiwanese with Type 2 Diabetes Mellitus

Overview

Journal Biomed J

Publisher Elsevier

Specialty General Medicine

Date 2021 May 9

PMID 33965355

Citations 4

Authors

Wai Kin Chan

Sung-Sheng Tsai

Yan-Rong Li

Wei-Yu Chou

Hsiao-Lien Chen

Szu-Tah Chen

Affiliations

Soon will be listed here.

Abstract

Background: To investigate the association between serum bilirubin (BIL) levels and the progression of albuminuria in type 2 diabetic Taiwanese.

Methods: Longitudinal data from January 2001 to June 2015 were retrospectively reviewed from Chang Gung Memorial Hospital in Taiwan. A total of 2877 type 2 diabetic patients with normal total BIL levels were divided into 4 groups according to BIL, with the highest BIL in the fourth group. The urinary albumin/creatinine ratio (UACR) trend and progression, as well as other laboratory measurements, were evaluated among the four groups. The cumulative incidence and Cox proportional hazard model analysis were performed to examine the relationship between BIL and the risk of albuminuria progression (AUPr).

Results: The mean duration of follow-up was 1.5 years (±1.37 years). The mean patient age, glycosylated hemoglobin level, and duration of diabetes were 62.52 years, 7.9%, and 3.94 years, respectively. A significant correlation was observed between BIL and both the UACR at baseline (P < 0.001) and the cumulative incidence of AUPr (log-rank test, P = 0.031). Hazard ratio (HR) analysis revealed that patients in the fourth BIL quartile had the lowest HR risk of AUPr among the four groups (adjusted HR = 0.70; 95% Confidence Interval = 0.56-0.89, P < 0.05).

Conclusions: Higher serum BIL levels are associated with a lower risk of AUPr in type 2 diabetes patients in Taiwan.

Citing Articles

Low Levels of Metrnl are Linked to the Deterioration of Diabetic Kidney Disease.

Chen J, Li Z, Xu F, Wang C, Li W, Lu J Diabetes Metab Syndr Obes. 2024; 17:959-967.

PMID: 38435635 PMC: 10908288. DOI: 10.2147/DMSO.S452055.

Association between serum total bilirubin and diabetic kidney disease in US diabetic patients.

Lv J, Shi X, Ma Q, Chen N, Fu M, Liu J Front Endocrinol (Lausanne). 2023; 14:1310003.

PMID: 38152124 PMC: 10752268. DOI: 10.3389/fendo.2023.1310003.

Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease.

Bianco A, Tiribelli C, Bellarosa C Biomedicines. 2022; 10(3).

PMID: 35327498 PMC: 8945513. DOI: 10.3390/biomedicines10030696.

Guards! Guards! How innate lymphoid cells ensure local law and order.

Hafner S Biomed J. 2021; 44(2):105-111.

PMID: 33994144 PMC: 8178564. DOI: 10.1016/j.bj.2021.04.007.

References

Katoh T, Kawamoto R, Kohara K, Miki T . Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Diabetic Patients. Int Sch Res Notices. 2016; 2015:480418. PMC: 4897282. DOI: 10.1155/2015/480418. View

Molitch M, DeFronzo R, Franz M, Keane W, Mogensen C, Parving H . Nephropathy in diabetes. Diabetes Care. 2003; 27 Suppl 1:S79-83. DOI: 10.2337/diacare.27.2007.s79. View

Huang Y, Lin K, Jiang Y, Chang C, Chung C, Chuang L . Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009. J Formos Med Assoc. 2012; 111(11):637-44. DOI: 10.1016/j.jfma.2012.09.006. View

Nishimura T, Tanaka M, Sekioka R, Itoh H . Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus. J Diabetes Complications. 2015; 29(8):1223-7. DOI: 10.1016/j.jdiacomp.2015.07.007. View

Kawamoto R, Ninomiya D, Hasegawa Y, Kasai Y, Kusunoki T, Ohtsuka N . Association between serum bilirubin and estimated glomerular filtration rate among elderly persons. PLoS One. 2014; 9(12):e115294. PMC: 4267840. DOI: 10.1371/journal.pone.0115294. View

Targher G, Bosworth C, Kendrick J, Smits G, Lippi G, Chonchol M . Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Clin Chem Lab Med. 2009; 47(9):1055-62. DOI: 10.1515/CCLM.2009.244. View

Ocadlik I, Hlinstakova S, Oravec S . Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum. Neuro Endocrinol Lett. 2011; 32(3):360-4. View

Sakoh T, Nakayama M, Tanaka S, Yoshitomi R, Ura Y, Nishimoto H . Association of serum total bilirubin with renal outcome in Japanese patients with stages 3-5 chronic kidney disease. Metabolism. 2015; 64(9):1096-102. DOI: 10.1016/j.metabol.2015.06.006. View

Fiorentino T, Prioletta A, Zuo P, Folli F . Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013; 19(32):5695-703. DOI: 10.2174/1381612811319320005. View

10.

Mashitani T, Hayashino Y, Okamura S, Tsujii S, Ishii H . Correlations between serum bilirubin levels and diabetic nephropathy progression among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 5]). Diabetes Care. 2013; 37(1):252-8. DOI: 10.2337/dc13-0407. View

11.

Fujii M, Inoguchi T, Sasaki S, Maeda Y, Zheng J, Kobayashi K . Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int. 2010; 78(9):905-19. DOI: 10.1038/ki.2010.265. View

12.

Stec D, Hosick P, Granger J . Bilirubin, renal hemodynamics, and blood pressure. Front Pharmacol. 2012; 3:18. PMC: 3278997. DOI: 10.3389/fphar.2012.00018. View

13.

Bakris G, Molitch M . Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care. 2014; 37(3):867-75. DOI: 10.2337/dc13-1870. View

14.

Toya K, Babazono T, Hanai K, Uchigata Y . Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus. J Diabetes Investig. 2014; 5(2):228-35. PMC: 4023588. DOI: 10.1111/jdi.12134. View

15.

Tapan S, Karadurmus N, Dogru T, Ercin C, Tasci I, Bilgi C . Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem. 2010; 44(4):300-3. DOI: 10.1016/j.clinbiochem.2010.12.003. View

16.

Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T . Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA. 2007; 298(12):1398-400. DOI: 10.1001/jama.298.12.1398-b. View

17.

Liu J, Dong H, Zhang Y, Cao M, Song L, Pan Q . Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels. Sci Rep. 2015; 5:9886. PMC: 4446899. DOI: 10.1038/srep09886. View

18.

Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L . Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond). 2013; 125(5):257-64. DOI: 10.1042/CS20120661. View

19.

Shin H, Jung Y, Rim H . Relationship of serum bilirubin concentration to kidney function and 24-hour urine protein in Korean adults. BMC Nephrol. 2011; 12:29. PMC: 3146921. DOI: 10.1186/1471-2369-12-29. View

20.

Marathe P, Gao H, Close K . American Diabetes Association Standards of Medical Care in Diabetes 2017. J Diabetes. 2017; 9(4):320-324. DOI: 10.1111/1753-0407.12524. View